CRMD Earnings
Latest Revenue101.9M
Latest Net Income26.0M
| Period | EPS | Revenue | Net Income | Rev YoY | EPS YoY |
|---|
| Q2 2026 | $0.33 | 101.9M | 26.0M | +156.5% | +13.8% |
| Q1 2026 | $0.48 | 127.4M | 38.6M | +226.1% | +50.0% |
| Q4 2025 | $0.18 | 128.6M | 14.0M | +312.1% | -18.2% |
| Q3 2025 | $1.42 | 104.3M | 108.6M | +810.2% | +2,940.0% |
| Q2 2025 | $0.29 | 39.7M | 19.8M | +4,829.3% | +216.0% |
| Q1 2025 | $0.32 | 39.1M | 20.6M | — | +228.0% |
| Q4 2024 | $0.22 | 31.2M | 13.5M | — | +184.6% |
| Q3 2024 | -$0.05 | 11.5M | -2776812 | — | +70.6% |
| Q2 2024 | -$0.25 | 806.1K | -14151489 | — | — |
| Q1 2024 | -$0.25 | 0 | -14466123 | — | — |
| Q4 2023 | -$0.26 | 0 | -14754029 | — | — |
| Q3 2023 | -$0.17 | 0 | -9744354 | — | — |
CorMedix (CRMD) — Earnings